Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 2, pp. 184-199
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 6, 2020
- Revision received August 19, 2020
- Accepted November 24, 2020
- Published first December 4, 2020.
Article Versions
- Previous version (December 4, 2020 - 06:11).
- Previous version (December 17, 2020 - 05:43).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Jefte M. Drijvers1,2,3,
- Jacob E. Gillis1,3,#,
- Tara Muijlwijk1,3,#,
- Thao H. Nguyen1,3,#,
- Emily F. Gaudiano1,3,
- Isaac S. Harris2,
- Martin W. LaFleur1,3,
- Alison E. Ringel2,
- Cong-Hui Yao2,
- Kiran Kurmi2,
- Vikram R. Juneja1,3,
- Justin D. Trombley1,3,
- Marcia C. Haigis2,*, and
- Arlene H. Sharpe1,3,*
- 1Department of Immunology, Blavatnik Institute and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts.
- 2Department of Cell Biology, Blavatnik Institute and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts.
- 3Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
- ↵*Corresponding Authors:
Arlene H. Sharpe, Department of Immunology, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 837, Boston, MA 02115. Phone: 617-432-6569; Fax: 617-432-6570; E-mail: arlene_sharpe{at}hms.harvard.edu; and Marcia C. Haigis, Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, LHRRB Room 301A, Boston, MA 02115. Phone: 617-432-6865; Fax: 617-432-6932; E-mail: marcia_haigis{at}hms.harvard.edu
↵#J.E. Gillis, T. Muijlwijk, and T.H. Nguyen contributed equally to this article.
February 2021
Volume 9, Issue 2
Volume 9, Issue 2
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
Jump to section
Advertisement